Before you sell to, join or invest in VeraDermics, Inc
MentionFox check on VeraDermics, Inc: only 1 source on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/veradermics-inc-form-d-24000001
Check VeraDermics, Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
VeraDermics, Inc filed a Form D with the Securities and Exchange Commission on 2024-12-10.
VeraDermics, Inc filed a Form D notice of an exempt securities offering with the SEC on December 10, 2024. VeraDermics, Inc trades on NYSE as MANE. The filing reports $66.57M sold. Its industry group is Other Health Care. It names John Childs (Director), Vladimir Coric (Director), Christopher Eklund (Director) (SEC Form D, December 10, 2024).
In its own words: “Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company.” (veradermics.com, checked November 1, 2026)
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like VeraDermics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-12-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns VeraDermics, Inc.
Free to see. No signup.
Get an email when VeraDermics, Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when VeraDermics, Inc raises, hires or launches. No email unless you switch it on.
Watch VeraDermics, Inc →Get the full cited report on VeraDermics, Inc
What the filing shows about VeraDermics, Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on VeraDermics, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives VeraDermics, Inc's address as 470 James Street, New Haven, CT 06513-3098.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Veradermics, Inc →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
VeraDermics, Inc is a registered filer with the SEC (CIK 1827635) and has filed since 2023-05-01. 4 filings are on record, the latest on 2026-05-15.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
VeraDermics, Inc's Form D of 2024-12-10 names John Childs, Vladimir Coric, Christopher Eklund and 4 more as its officers, directors or promoters.
Its new offerings report $246.57M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 863 filings in Other Health Care, totalled by week.
John Childs is named as Director on the Form D that VeraDermics, Inc filed with the SEC on 10 December 2024, one of 7 people that filing names.
Vladimir Coric is named as Director on the Form D that VeraDermics, Inc filed with the SEC on 10 December 2024, one of 7 people that filing names.
Christopher Eklund is named as Director on the Form D that VeraDermics, Inc filed with the SEC on 10 December 2024, one of 7 people that filing names.
Jane Grant-Kels is named as Director on the Form D that VeraDermics, Inc filed with the SEC on 10 December 2024, one of 7 people that filing names.
Reid Waldman is named as Executive Officer and Director on the Form D that VeraDermics, Inc filed with the SEC on 10 December 2024, one of 7 people that filing names.
Amanda Birdsey-Benson is named as Director on the Form D that VeraDermics, Inc filed with the SEC on 10 December 2024, one of 7 people that filing names.
Patrick Enright is named as Director on the Form D that VeraDermics, Inc filed with the SEC on 10 December 2024, one of 7 people that filing names.
7 people named on the filing — 1 holding an executive role and 6 as directors only.
Named as of the 2024-12-10 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about VeraDermics, Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on VeraDermics, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on VeraDermics, Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist VeraDermics, IncYou get an alert in MentionFox the next time this company shows up.
If you're behind VeraDermics, Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for VeraDermics, Inc. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/veradermics-inc-form-d-24000001